ESSA Pharma to Participate in Two Upcoming Investor Conferences
ESSA Pharma (NASDAQ: EPIX) announced its participation in two investor conferences, aimed at discussing its innovative prostate cancer therapies.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ESSA Pharma (NASDAQ: EPIX) announced its participation in two investor conferences, aimed at discussing its innovative prostate cancer therapies. The events include:
- Jefferies London Healthcare Conference: November 17, 2022, at 3:15 p.m. GMT.
- Piper Sandler 34th Annual Healthcare Conference: November 29, 2022, at 4:30 p.m. ET.
David R. Parkinson, CEO, along with other executives, will host one-on-one meetings. A live webcast of the Jefferies chat will be available on ESSA's website, archived for 90 days.
Details
News Market Reaction – EPIX
The recorded move for EPIX in the trading session of this news was +7.17%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Nov. 10, 2022 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be participating in two upcoming investor conferences.
David. R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will participate in and host one-on-one meetings. Peter Virsik, ESSA's Chief Operating Officer, and David S. Wood, ESSA's Chief Financial Officer, will also be participating in one-on-one meetings
Event: Jefferies London Healthcare Conference
Format: Fireside Chat
Date: Thursday, November 17, 2022
Time: 3:15 p.m. GMT / 10:15 a.m. ET
Event: Piper Sandler 34th Annual Healthcare Conference
Format: Fireside Chat
Date: Tuesday, November 29, 2022
Time: 4:30 p.m. ET
A live webcast of the Jefferies fireside chat can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the event, the webcast will be archived on the ESSA website for 90 days.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.
View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-participate-in-two-upcoming-investor-conferences-301673393.html
SOURCE ESSA Pharma Inc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.